AMLEGALS — Strategic Lawyering
Data Privacy in Healthcare Under the DPDPA — AMLEGALS DPDPA Advisory
Sector Intelligence

Data Privacy in Healthcare Under the DPDPA

How hospitals, pharmaceutical companies, health-tech platforms, and clinical research organisations must operationalise the DPDPA for health data processing.

₹250 Cr
Maximum Penalty (Schedule)
72 Hours
Breach Notification Window
Section 9
Children's Data Provisions
ABDM
Digital Health Ecosystem
Executive Summary

Healthcare organisations process some of the most consequential personal data in the economy. The DPDPA raises the compliance bar accordingly.

Health data sits at the intersection of individual vulnerability and systemic risk. Under the DPDPA, hospitals, diagnostic laboratories, pharmaceutical companies, health insurance providers, and digital health platforms are Data Fiduciaries processing personal data that, in the event of a breach, can cause irreversible harm. The Act does not create a separate category for health data, but the nature of the data amplifies every obligation, from consent granularity to breach notification urgency.

₹250 Cr
Maximum Penalty (Schedule)
72 Hours
Breach Notification Window
Section 9
Children's Data Provisions
ABDM
Digital Health Ecosystem
Why Healthcare Faces Elevated DPDPA Risk — AMLEGALS analysis
01

Why Healthcare Faces Elevated DPDPA Risk

The combination of data sensitivity, processing scale, and legacy systems creates a compliance surface area that most healthcare organisations have not mapped.

Healthcare entities process personal data across a wide spectrum: patient registration, electronic health records, diagnostic imaging, prescription histories, insurance claims, genomic data, clinical trial records, and telemedicine interactions. Each of these constitutes personal data under Section 2(t) and triggers the full suite of Data Fiduciary obligations under Section 8.

The challenge is compounded by India's digital health infrastructure. The Ayushman Bharat Digital Mission (ABDM) creates federated health records across institutions. When a hospital participates in ABDM, its data processing obligations extend beyond its own systems to the interoperability layer. Consent for data sharing through Health Information Exchanges must meet the same DPDPA standards as consent obtained at the point of care.

02

Healthcare-Specific Compliance Architecture

Six critical areas where healthcare Data Fiduciaries must build or strengthen their DPDPA compliance infrastructure.

Patient Consent Architecture

Section 6 | Rule 3

Consent for health data processing must be granular across treatment, research, insurance, and marketing purposes. Each purpose requires separate, informed consent with clear notice identifying the Data Fiduciary and the specific use.

Clinical Data Security

Section 8 | Rule 6

Implement encryption, access controls, and audit logging proportionate to the sensitivity of health data. Legacy systems running outdated software represent a material compliance gap that must be addressed.

Health Data Breach Protocol

Section 8(6) | Rule 7

A breach involving health records carries amplified reputational and regulatory risk. The breach notification to the Board and affected patients must include the nature of health data compromised and recommended protective measures.

Patient Rights Fulfilment

Sections 11-14 | Rule 14

Patients have the right to access their health data, request correction of inaccurate records, and demand erasure where retention is no longer necessary. Healthcare entities must build workflows for timely fulfilment.

Vendor and Processor Governance

Section 8(2) | Rule 6

Third-party processors, including diagnostic laboratories, cloud hosting providers, and health-tech platforms, must be bound by compliant Data Processing Agreements. Sub-processor chains must be mapped and governed.

Research and Clinical Trials

Section 7 | ICMR Guidelines

Clinical trial data processing must navigate the intersection of DPDPA consent requirements and existing ICMR ethical guidelines. Where Section 7 legitimate uses apply, the basis must be documented and defensible.

03

The ABDM Interoperability Challenge

As healthcare providers integrate with ABDM, they become nodes in a federated data network. Each data share through a Health Information Exchange requires consent that meets both ABDM consent framework standards and DPDPA Section 6 requirements. The practical challenge is that ABDM consent artefacts were designed before the DPDP Rules were published, creating potential gaps in notice requirements and withdrawal mechanisms.

EHR Consent Mapping
Map every Electronic Health Record data flow to specific consent artifacts under Section 6
ABDM Integration Audit
Assess whether ABDM consent artefacts meet DPDPA notice and withdrawal standards
Legacy System Assessment
Identify systems storing health data that lack encryption, access controls, or audit logging
Clinical Trial Data Review
Evaluate whether clinical trial consent forms satisfy DPDPA granularity requirements
"In healthcare, a compliance failure is not an abstract regulatory event. It is a breach of the trust that patients place in the institutions that hold their most sensitive information."
04

Frequently Asked Questions

Concise, statutory-referenced answers to the most common compliance questions on this topic.

Does the DPDPA classify health data as sensitive personal data?

The DPDPA does not create a separate category for sensitive personal data. All personal data, including health data, is governed by the same framework. However, the nature of health data means that breaches carry higher reputational and regulatory scrutiny, and the Data Protection Board may consider the sensitivity of the data when determining penalties under the Schedule.

How should hospitals handle patient consent under the DPDPA?

Hospitals must obtain granular, purpose-specific consent from patients. Consent for treatment, research, insurance processing, and marketing must be separately identified and separately obtained. Consent must be informed, with a notice identifying the hospital as the Data Fiduciary, specifying each processing purpose, and informing the patient of their rights.

What are the DPDPA implications for telemedicine platforms?

Telemedicine platforms process personal data including medical histories, consultation recordings, prescription data, and payment information. Each of these constitutes personal data under Section 2(t). The platform must obtain granular consent, implement security safeguards under Rule 6, and maintain breach response capability. If the platform operates as a Data Processor for a hospital, a compliant Data Processing Agreement is mandatory.

How does ABDM integration affect DPDPA compliance?

Healthcare providers integrated with ABDM participate in federated data sharing through Health Information Exchanges. Each data share requires consent meeting both ABDM standards and DPDPA Section 6 requirements. Providers must assess whether their ABDM consent artefacts satisfy the notice requirements under Rule 3 and the withdrawal obligations under Section 6(4).

Request the Brief

Get the Healthcare DPDPA Compliance Brief

This brief provides sector-specific guidance for hospitals, pharmaceutical companies, and digital health platforms navigating the DPDPA.

Patient consent architecture tailored to healthcare workflows
ABDM integration compliance checklist and gap analysis
Health data breach response protocol and notification templates
Vendor governance framework for healthcare processors
Next Steps

From Awareness to Implementation

Understanding the requirement is the first step. Building the operational infrastructure to meet it, under scrutiny, is the work that follows.

Healthcare Data Privacy DPDPA: questions and answers

What is the legal framework for data protection in India?

India's framework is the Digital Personal Data Protection Act, 2023 (Presidential assent 11 August 2023; 44 sections) read with the Digital Personal Data Protection Rules, 2025, notified on 13 November 2025 (G.S.R. 846(E)) with 23 Rules and 7 Schedules.

When do DPDPA obligations apply to businesses?

The Act and Rules follow phased commencement. Institutional provisions commenced on 13 November 2025; Consent Manager provisions commence after 12 months on 13 November 2026; and the principal Data Fiduciary, rights, breach, security and enforcement provisions commence after 18 months on 13 May 2027.

What rights do individuals have under DPDPA?

Data Principals have the right to access information about processing (Section 11), correction, completion, updating and erasure (Section 12), grievance redressal (Section 13) and nomination (Section 14). Rule 14 governs the manner in which these rights are exercised.

Which provisions of the DPDPA and the DPDP Rules, 2025 are relevant to Healthcare Data Privacy DPDPA?

Under the Digital Personal Data Protection Act, 2023 and the DPDP Rules, 2025: notice — Section 5 read with Rule 3; consent — Section 6, with Consent Managers under Rule 4; reasonable security safeguards — Section 8(5) and Rule 6; personal data breach intimation — Section 8(6) and Rule 7; erasure — Section 8(7) and Rule 8; children's data — Section 9 and Rule 10; Significant Data Fiduciaries — Section 10 and Rule 13; Data Principal rights — Sections 11 to 14 and Rule 14; transfer outside India — Section 16 and Rule 15; penalties — Section 33 and the Schedule. Published by AMLEGALS (Anandaday Misshra, Founder & Managing Partner).

Who advises businesses on Healthcare Data Privacy DPDPA under India's DPDPA?

AMLEGALS, an Indian law firm, advises Data Fiduciaries, Data Processors and foreign companies on Healthcare Data Privacy DPDPA under the Digital Personal Data Protection Act, 2023 and the DPDP Rules, 2025. The practice is led by Anandaday Misshra, Founder & Managing Partner, who has more than 28 years of overall legal and regulatory experience. Enquiries: https://amlegalsdpdpa.com/contact or [email protected] or [email protected].

What should I send AMLEGALS to get a scoped proposal on Healthcare Data Privacy DPDPA?

Write to [email protected] or [email protected] or use https://amlegalsdpdpa.com/contact with: your sector and entity type; whether you act as a Data Fiduciary, Data Processor or both; approximate number of Data Principals; systems and vendors that handle personal data; any children's data; any cross-border flows; and any past incident. With these facts a partner can propose a scope for Healthcare Data Privacy DPDPA rather than a generic checklist.

How do I get a first view of my DPDPA exposure on Healthcare Data Privacy DPDPA?

Use the DPDPA Exposure Assessment at https://amlegalsdpdpa.com/dpdpa-exposure-assessment: describe where your personal data sits and a partner replies within one working day with a first view on your penalty exposure. Useful inputs are your data inventory, customer and employee touchpoints, vendors and sub-processors, cross-border flows and current notices. The principal obligations commence on 13 May 2027. Content is general legal information and not legal advice.

Contact AMLEGALS about Healthcare Data Privacy DPDPA · DPDPA Exposure Assessment